Literature DB >> 7566501

The neurotoxin, beta-N-methylamino-L-alanine (BMAA) interacts with the strychnine-insensitive glycine modulatory site of the N-methyl-D-aspartate receptor.

C N Allen1, I Omelchenko, S M Ross, P Spencer.   

Abstract

Electrophysiological and receptor binding techniques were used to determine whether the neurotoxin beta-N-methylamino-L-alanine (BMAA), a monocarboxylic amino acid, can act at the strychnine-insensitive glycine modulatory site to modify the activity of N-methyl-D-aspartate receptors. DL-BMAA but not L-BMAA reversibly potentiated the amplitude of NMDA-activated currents. Neither DL-BMAA nor L-BMAA were able independently to active currents. The reversal potential and the potential-dependence of the amplitude were not affected by DL-BMAA. The DL-BMAA effect was reversibly antagonized by 7-chlorokynurenic acid. Concentration jump experiments showed that the time course of the "off" response of NMDA-activated currents in the presence of DL-BMAA is faster than in the presence of glycine, suggesting that DL-BMAA dissociates from the receptor more rapidly than glycine. DL-BMAA produced a concentration-dependent displacement of [3H]glycine binding which was additive with that of 7-chlorokynurenic acid. These data indicate that D-BMAA could act as a stereospecific modulator of NMDA receptor function by acting as an agonist at the strychnine-insensitive glycine modulatory site of the NMDA receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566501     DOI: 10.1016/0028-3908(95)00043-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue.

Authors:  Laura R Snyder; Reyniel Cruz-Aguado; Martin Sadilek; Douglas Galasko; Christopher A Shaw; Thomas J Montine
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

2.  Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs.

Authors:  Larry E Brand; John Pablo; Angela Compton; Neil Hammerschlag; Deborah C Mash
Journal:  Harmful Algae       Date:  2010-09-01       Impact factor: 4.273

3.  Neurotoxic potential of three structural analogs of beta-N-oxalyl-alpha,beta-diaminopropanoic acid (beta-ODAP).

Authors:  I A Omelchenko; R K Jain; M A Junaid; S L Rao; C N Allen
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

4.  Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.

Authors:  Paul Alan Cox; Sandra Anne Banack; Susan J Murch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

Review 5.  Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Int J Environ Res Public Health       Date:  2011-09-29       Impact factor: 3.390

Review 6.  Non-Proteinogenic Amino Acid β-N-Methylamino-L-Alanine (BMAA): Bioactivity and Ecological Significance.

Authors:  Olga A Koksharova; Nina A Safronova
Journal:  Toxins (Basel)       Date:  2022-08-07       Impact factor: 5.075

Review 7.  Cyanotoxins and the Nervous System.

Authors:  James S Metcalf; Maeve Tischbein; Paul Alan Cox; Elijah W Stommel
Journal:  Toxins (Basel)       Date:  2021-09-16       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.